Nextage Therapeutics Ltd (NXTG) — Strategic Asset Allocation Index
Nextage Therapeutics Ltd (NXTG) has a Strategic Asset Allocation Index of 4.5% as of June 2022. Strategic assets (PP&E of ILA106.00K plus long-term investments of ILA-) total ILA106.00K, measured against net assets of ILA2.36 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See how leveraged is Nextage Therapeutics Ltd's balance sheet to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Nextage Therapeutics Ltd Strategic Asset Allocation Index (2017–2021)
This chart shows how Nextage Therapeutics Ltd's Strategic Asset Allocation Index has evolved across 4 annual periods from 2017 to 2021. As of June 2022, the index stands at 4.5%, representing strategic assets of ILA106.00K against net assets of ILA2.36 Million ILA. For live market cap and overall valuation, see how much is Nextage Therapeutics Ltd worth.
Annual Strategic Asset Allocation Index for Nextage Therapeutics Ltd (2017–2021)
The table below presents the year-by-year Strategic Asset Allocation Index for Nextage Therapeutics Ltd from 2017 to 2021, covering 4 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See NXTG total equity for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (ILA) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 22.5% | ILA116.00K | ILA116.00K | ILA- | ILA516.00K | ▲ +5.9 pp |
| 2020 | 16.6% | ILA240.00K | ILA240.00K | ILA- | ILA1.45 Million | ▲ +14.8 pp |
| 2019 | 1.8% | ILA65.00K | ILA65.00K | ILA- | ILA3.66 Million | ▼ -0.8 pp |
| 2017 | 2.6% | ILA116.00K | ILA116.00K | ILA- | ILA4.44 Million | — |